ARCHIVES

European Commission Approves Subcutaneous Rituximab

This article is from The Cancer Letter archive.

Vol. 37 No. 3 | March 28, 2014

Download PDF Visit The Full Archive

Related Articles

Avon, four companies Fund NABCO Patient Information Services

January 28, 1994

Crizotinib Eliminated Tumors In 7 of 8 Children with ALCL

May 25, 2012

Zvi Fuks of Memorial Sloan-Kettering arrested and charged with securities fraud related to sale of ImClone stock.

March 11, 2005

Capitol Hill: Groups Warn Of Harm From Bill To Promote Breast Self-Exams

May 29, 2009

In Brief: NIH Funding For Shannon Awards To Fall, Eight Institutes Decide Not To Participate

August 13, 1993

Rauscher Says He May Leave, But Will Stay Through June

February 6, 1976